PROGRAM |
DISCIPLINE |
HEALTH THEMES |
|
|---|---|---|---|
| Maternal, Child and Adolescent Health | International Development | Maternal, Newborn + Child Health |
A significant barrier to reducing maternal mortality and severe morbidity globally is a lack of innovative medicines. This is reflective of a broad under-investment in pharmaceutical research and development (R&D) of medicines for pregnancy-specific conditions.
The Accelerating Innovation for Mothers (AIM) project was established in 2020 to develop a database of candidates being developed and evaluated for priority maternal health conditions for the period 2000 to 2021 and to develop new Target Product Profiles for new medicines in this area.
In this project, the student will work on advancing the ‘drug pipeline’ for innovative medicines in maternal and perinatal health. Available projects include:
- research into what medicines are available for specific life-threatening conditions in maternal and perinatal health
- how to improve the development of Target Product Profiles for novel and repurposed medicines in maternal and perinatal health.
These projects will allow the student to gain experience in global maternal and perinatal health research, systematic review and quantitative analysis methodologies, with a view to a scientific publication.
Contact
Dr Annie McDougall
Research Officer
annie.mcdougall@burnet.edu.au
Professor Joshua Vogel
Senior Principal Research Fellow; Deputy Discipline Head, International Development; Co-Head, Global Women’s and Newborn’s Health Group
joshua.vogel@burnet.edu.au
More Student Projects
burnet.edu.au/studentprojects
View projects
Why study at Burnet?
When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.
Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.
Find out more Student Projects